Anzeige
Meldung des Tages: GOLD-AUSBRUCH: Von der PEA zum Milliarden-Potenzial

Oncolytics Biotech Aktie News

Aktie
WKN:  A2JMW5 ISIN:  CA6823108759 US-Symbol:  ONCY Branche:  Biotechnologie Land:  Kanada
1,24 $
-0,03 $
-2,36%
1,0483 € 23.01.26
Depot/Watchlist
Marktkapitalisierung *
62,33 Mio. €
Streubesitz
94,71%
KGV
-3,21
Index-Zuordnung
Nasdaq Composite Index

Oncolytics Biotech News

14.01.26 - PR Newswire
Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff
Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff PR Newswire
12.01.26 - PR Newswire
Fast-Tracking the $537B Cancer Cure: How Accelerated Approvals Reshaping Oncology in 2026
Fast-​Tracking the $537B Cancer Cure: How Accelerated Approvals Reshaping Oncology in 2026 PR Newswire
07.01.26 - PR Newswire
How $594B in Precision Tech is Cracking the Metastatic Cancer Code
How $594B in Precision Tech is Cracking the Metastatic Cancer Code PR Newswire
31.12.25 - PR Newswire
Smart Oncology: 5 Stocks Chasing the $317B Prize
Smart Oncology: 5 Stocks Chasing the $317B Prize PR Newswire
16.12.25 - PR Newswire
Immunotherapy Breakthroughs Turn Cold GI Tumors Hot as Market Tops $443B
Immunotherapy Breakthroughs Turn Cold GI Tumors Hot as Market Tops $443B PR Newswire
12.12.25 - PR Newswire
Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance
Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance PR Newswire
28.10.25 - PR Newswire
Oncolytics Biotech® Reports Updated Anal Cancer Data Showing Objective Response Rate More Than Double the Current Standard of Care
Oncolytics Biotech® Reports Updated Anal Cancer Data Showing Objective Response Rate More Than Double the Current Standard of Care PR Newswire
20.10.25 - PR Newswire
Oncolytics Biotech® Files Circular/Prospectus for Special Meeting of Shareholders To Change Jurisdiction of Incorporation to Nevada
Oncolytics Biotech® Files Circular/Prospectus for Special Meeting of Shareholders To Change Jurisdiction of Incorporation to Nevada PR Newswire
29.09.25 - PR Newswire
Oncolytics Biotech® Announces Update for Potential First-Line Pancreatic Cancer Registration Study
Oncolytics Biotech® Announces Update for Potential First-​Line Pancreatic Cancer Registration Study PR Newswire
16.09.25 - PR Newswire
Cancer Immunotherapy Surge Drives $258B Market as FDA Accelerates Approvals
Cancer Immunotherapy Surge Drives $258B Market as FDA Accelerates Approvals PR Newswire
16.09.25 - PR Newswire
Cancer Immunotherapy Surge Drives $258B Market as FDA Accelerates Approvals
Cancer Immunotherapy Surge Drives $258B Market as FDA Accelerates Approvals PR Newswire
16.09.25 - PR Newswire
Oncolytics Biotech® Provides Update on GOBLET Study Progress and U.S. Site Expansion
Oncolytics Biotech® Provides Update on GOBLET Study Progress and U.S. Site Expansion PR Newswire
08.09.25 - PR Newswire
Breakthrough Therapy Designations Surge as $50B Cancer Drug Partnerships Reshape Market
Breakthrough Therapy Designations Surge as $50B Cancer Drug Partnerships Reshape Market PR Newswire
08.09.25 - PR Newswire
Breakthrough Therapy Designations Surge as $50B Cancer Drug Partnerships Reshape Market
Breakthrough Therapy Designations Surge as $50B Cancer Drug Partnerships Reshape Market PR Newswire
08.09.25 - PR Newswire
Oncolytics Biotech® Highlights Strong Efficacy and Translational Data in Metastatic Colorectal Cancer; Will Advance Regulatory Pathway Discussions
Oncolytics Biotech® Highlights Strong Efficacy and Translational Data in Metastatic Colorectal Cancer; Will Advance Regulatory Pathway Discussions PR Newswire
02.09.25 - PR Newswire
Breakthrough Cancer Therapies Fuel Regulatory Momentum as Global Market Expands
Breakthrough Cancer Therapies Fuel Regulatory Momentum as Global Market Expands PR Newswire
02.09.25 - PR Newswire
Breakthrough Cancer Therapies Fuel Regulatory Momentum as Global Market Expands
Breakthrough Cancer Therapies Fuel Regulatory Momentum as Global Market Expands PR Newswire
02.09.25 - PR Newswire
Oncolytics Biotech® Provides Updated Clinical Safety Data for Pelareorep, Including Across Multiple Gastrointestinal Tumors
Oncolytics Biotech® Provides Updated Clinical Safety Data for Pelareorep, Including Across Multiple Gastrointestinal Tumors PR Newswire
28.08.25 - PR Newswire
FDA Tightens Survival Standards as Cancer Drug Pipeline Hits $866B Market Milestone
FDA Tightens Survival Standards as Cancer Drug Pipeline Hits $866B Market Milestone PR Newswire
28.08.25 - PR Newswire
FDA Tightens Survival Standards as Cancer Drug Pipeline Hits $866B Market Milestone
FDA Tightens Survival Standards as Cancer Drug Pipeline Hits $866B Market Milestone PR Newswire

Newssuche

Videos

newspaper
22.01.26 -5,56%
Trading Insights vom 22.01.26
Preisschock bei Erdgas! Was sind die Gründe, wie geht man damit um? Gold auf neuem Allzeithoch: wie ... Mehr »